Biosimilars Update

Daktari Biotechnology is applying Bacmam expression technology to develop insulin, interferon and erythropoietin biosimilars products for managing and treating health needs related to diabetes, infectious diseases, inflammation, cancer and anemia. Work has been initiated through CROs with the goal to produce the therapeutic proteins in human cell lines.